Laboratorios Farma | ROVI - Gross Profit On Sales

Stock Price
79.80
Daily Change
-0.70 -0.87%
Monthly
1.59%
Yearly
52.00%
Q1 Forecast
76.74

Laboratorios Farma reported EUR105.28M in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Almirall EUR 429.87M 180.02M Dec/2025
Avita Medical AUD 14.31M 639K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Moderna USD 226M 583M Dec/2025
Organon & Co USD 854M 3M Dec/2025
Pharma Mar EUR 86.7M 53.34M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.15B 223.6M Dec/2025
Xeris Pharmaceuticals USD 72.15M 8.77M Dec/2025